Business Directory, Press Releases, Jobs, Products, Services, Articles
Businesses Articles Press Releases Follow @PRcom
Press Release Pricing | News by Category | News by Country | News by US Region | Recent News | News on Your Site

Press Releases

SMi Group

Press Release

Receive press releases from SMi Group: By Email RSS Feeds:

SMi's Asthma & COPD Conference Next Week in London

SMi Group reports: Limited availability on Managers Special Discount

London, United Kingdom, April 07, 2018 --( Last call (*Managers Special offer - £500 savings) on SMi's Asthma & COPD conference, taking place on 11 – 12 April in London - to Directors, Principle scientists, Senior scientists, Associate directors, Managing directors, Medical directors, Pharmaceutical experts, Group leaders, Inhalation toxicologists of: clinical pharmacology; respiratory medicine/ science; respiratory immunology; pulmonary specialty; respiratory physiology.

Organisers are glad to welcome Richard Marsden, Chief Executive Officer of Synairgen to the speaker line-up on the Day 1 of the event

Event in programme in brief:

April 11 (Day 1) will have presentations covering:
Novel approaches to management and prevention of COPD exacerbations (Wisla Wedzicha of Imperial College London);
Development of inhaled interferon beta for the treatment and/or prevention of virus-induced exacerbations of Asthma and COPD (Richard Marsden, Chief Executive Officer, Synairgen);
Adherence to inhaled therapy - the challenges and opportunities of digital technologies (Richard Costello, Professor, Royal College of Surgeons in Ireland);
Regulatory requirements, human factors and usability for inhaled drug- device combination products (Quan Yang, Pharmaceutical Assessor, MHRA).

In addition - a number of other exciting presentations covering Novel Therapeutic Approaches to COPD & Asthma and Advancements in Inhalation Device Development.

April 12 (Day 2) will cover topics of:
Genetic Driven Drug Discovery for Respiratory Disease (Jonathan Phillips, Principal Scientist, Inflammation, Amgen);
New Therapeutic Targets for COPD (Peter Barnes, Professor of Thoracic Medicine and Head of Respiratory Medicine, National Heart & Lung Institute);
From efficacy to effectiveness, the Salford lung study in COPD and now asthma (David Leather, Medical Vice President, Global Respiratory Franchise, GSK)

In addition - multiple presentations on the following areas: Early Detection - Molecular Phenotyping and Biomarker Development, Real World Studies and Disease Modifying Drugs and The Emerging Role of Smooth Muscle in Asthma.

To secure £500 Managers Special Discount* register your interest at or contact Kieran Ronaldson on +44 (0)20 7827 6744 /

Event is sponsored by: Vitalograph

+44 (0)20 7827 6000

Stay Connected
LinkedIn – search "SMi Pharma"
Twitter – @SMIpharm and #AsthmaCOPDsmi

Asthma & COPD | 11 - 12 April 2018 | Copthorne Tara Hotel, London, UK
Contact Information
SMi Group
Luda Durneva
+44 (0) 207 827 0000

Click here to view the list of recent Press Releases from SMi Group
Promote Your Business